Compound information
- Natural Products
- ZC419605
- Molecular Formula
- C14H16N2O5S
- Molecular Weight
- 324.077992612 g/mol
- Structure
-
- IUPAC Name
- (Z)-4-oxo-4-(4-pyrrolidin-1-ylsulfonylanilino)but-2-enoic acid
- InChI
- InChI=1S/C14H16N2O5S/c17-13(7-8-14(18)19)15-11-3-5-12(6-4-11)22(20,21)16-9-1-2-10-16/h3-8H,1-2,9-10H2,(H,15,17)(H,18,19)/b8-7-
- InChI Key
- IXCLSMGDZDOYEU-FPLPWBNLSA-N
- SMILES
- O=C(O)/C=C\C(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1
- Source
- ZINC000016669788
Warheads
- Acrylamide
-
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 103.78 Å2 | LogP | 0.954 |
LogS | -2.868 | LogD | 0.461 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.03 |
HIA | 0.964 | F20 % | 0.991 |
F30 % | 0.556 | Caco-2 | -5.298 |
MDCK | -5.425 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.066 | PPB | 93.605 |
VD | 0.883 | Fu | 0.356 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.007 | CYP1A2 substrate | 0.544 |
CYP2A6 substrate | 0.448 | CYP2B6 substrate | 0.51 |
CYP2C19 inhibitor | 0.013 | CYP2C19 substrate | 0.646 |
CYP2C8 substrate | 0.673 | CYP2C9 inhibitor | 0.088 |
CYP2C9 substrate | 0.935 | CYP2D6 inhibitor | 0.071 |
CYP2D6 substrate | 0.431 | CYP2E1 substrate | 0.628 |
CYP3A4 inhibitor | 0.032 | CYP3A4 substrate | 0.494 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.51 | CL | 1.651 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.025 | Hepatotoxicity | 0.834 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.006 |
FDAMDD | 0.077 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.051 | Eye Corrosion | 0.002 |
Eye Irritation | 0.09 | Respiratory Toxicity | 0.045 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.498 | IGC50 | 2.155 |
LC50FM | -0.309 | LC50DM | 3.23 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.163 | NR-AR-LBD | 0.304 |
NR-AhR | 0.016 | NR-Aromatase | 0.027 |
NR-ER | 0.182 | NR-ER-LBD | 0.327 |
NR-PPAR-gamma | 0.184 | SR-ARE | 0.757 |
SR-ATAD5 | 0.308 | SR-HSE | 0.004 |
SR-MMP | 0.014 | SR-p53 | 0.088 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.